Spyre Therapeutics, Inc.SYRENASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
3Y CAGR+303.0%
5Y CAGR+147.3%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+303.0%/yr
vs -7.1%/yr prior
5Y CAGR
+147.3%/yr
Recent acceleration
Acceleration
+310.2pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
92.4x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $54.34M | +8972.5% |
| 2024 | $599000.00 | +100.6% |
| 2023 | $-96.51M | -11728.1% |
| 2022 | $830000.00 | +7645.5% |
| 2021 | $-11000.00 | -101.9% |
| 2020 | $588000.00 | -71.7% |
| 2019 | $2.08M | +86.5% |
| 2018 | $1.11M | +153.4% |
| 2017 | $440000.00 | +111.5% |
| 2016 | $208000.00 | - |